Category: Pharma Industry

Novo Nordisk’s 340B Arkansas Lawsuit Reassigned to Judge Who Previously Ruled Against Drugmakers

November 9, 2023 William Newton, Associate Editor/Senior Writer Views

Novo Nordisk and the Arkansas Insurance Department are at odds over whether a federal district court should intervene in the enforcement of Arkansas' 340B contract pharmacy law.

A federal district court transferred drugmaker Novo Nordisk’s lawsuit challenging Arkansas’ 340B contract pharmacy law to a judge who previously [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Louisiana Provider Group to Intervene in 340B Contract Pharmacy Lawsuit

November 9, 2023 William Newton, Associate Editor/Senior Writer Views

A federal district judge allowed the Louisiana Primary Care Association's to intervene in a second drug industry lawsuit challenging Louisiana's 340B contract pharmacy law.

A federal judge allowed a Louisiana provider group to join the state attorney general in defending Louisiana’s 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Hospitals Charge Higher Commercial Insurance Prices, Says PhRMA Funded Report

November 9, 2023 Rich Daly, Editor in Chief Views

Neil Masia, Ph.D., authored a Health Capital Group report that found 340B hospitals charge higher commercial insurance prices than non-340B hospitals.

The average hospital in the 340B program charges commercial insurers more than non-340B hospitals, according to a new report, which [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GlaxoSmithKline Posts Refund Notice on HRSA Website

November 9, 2023 Rich Daly, Editor in Chief Views

GlaxoSmithKline and Pfizer announced updates to their 340B contract pharmacy policies to comply with new state laws that will take effect in July.

GlaxoSmithKline owes refunds to 340B providers, according to a notice posted on the Health Resources and Services Administration’s Office of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lilly Reinstates Tighter 340B Contract Pharmacy Restrictions

November 7, 2023 William Newton, Associate Editor/Senior Writer Views

Eli Lilly is conducting government approved 340B provider audits that for the first time look for certain Medicaid health plan duplicate discounts.

Pharmaceutical giant Eli Lilly this week announced it would reinstate tighter 340B contract pharmacy restrictions for all covered entity types. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Industry Pushes Federal Court to Block Louisiana’s 340B Contract Pharmacy Law Without Trial

November 7, 2023 William Newton, Associate Editor/Senior Writer Views

PhRMA has asked a federal district judge to block Louisiana's 340B contract pharmacy law, Act 358, which took effect Aug. 1.

An influential drug industry trade group recently urged a federal judge to rule on its suit against Louisiana’s 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Arkansas Urges Federal Court to Reject Novo Nordisk’s Challenge to 340B Contract Pharmacy Law

November 7, 2023 William Newton, Associate Editor/Senior Writer Views

All drugmaker suits against Arkansas Act 1103 in federal district court should appear before Judge Billy Roy Wilson, AID said in a recent filing.

The Arkansas Insurance Department (AID) recently asked a federal district judge to dismiss Novo Nordisk’s lawsuit that challenges Arkansas’ state [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sixth Drugmaker Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

November 2, 2023 William Newton, Associate Editor/Senior Writer Views

Drugmaker Organon has loosened its 340B contract pharmacy restrictions in Arkansas and Louisiana in response to state laws.

Organon, a Merck spinoff with a focus on women’s health, yesterday became the sixth drugmaker to loosen or end its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Lobbying Still on Track for Record Year

November 2, 2023 Rich Daly, Editor in Chief Views

Darbin Wofford, a health policy advisor at Third Way, said his organization is urging Congressional Democrats to adopt 340B program reforms.

Lobbying on 340B issues in 2023 remains on track for a record-breaking year, according to recently released congressional lobbying reports. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Program May Lead to Lower Charity Care, Says Drug Industry-Backed AIDS Group

November 2, 2023 William Newton, Associate Editor/Senior Writer Views

Brandon Macsata, CEO of ADAP Advocacy, said the group plans to publish data from its ongoing study on the 340B program later this year.

Enrollment in the 340B program was linked to diminished spending on charity care, according to preliminary findings from an ongoing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live